摘要
随着肿瘤治疗手段的进展,肿瘤患者的生存时间与生存质量得到了极大的改善,与此同时,细胞毒类药物及靶向治疗等新型抗肿瘤治疗所导致的心血管事件也与日俱增,并且影响着肿瘤患者的生存率与死亡率,由此引起了越来越多学者的关注。在此基础上,肿瘤心脏病学应运而生,其是一门旨在研究肿瘤患者心脏病诊断与治疗的新兴学科,其中抗肿瘤治疗所致心脏疾病是研究重点。笔者主要对抗肿瘤治疗所致心脏毒性的最新研究进展作一综述。
With the improvement of cancer therapy,the survival time and quality of life of patients have been greatly improved.However,in the meanwhile,the cardiovascular events caused by cytotoxic drugs and targeted therapy are increasing day by day,and affecting the survival and mortality of cancer patients.This attracts more and more attention.On the basis of above,onco-cardiology comes into being which aims to study the diagnosis and treatment of heart disease in cancer patients.The heart disease caused by anti-tumor treatment is the focus of onco-cardiology research.Here,we review the latest advances in the research progress of antitumor treatment-induced cardiotoxicity.
作者
孙星星
闵大六
Sun Xingxing;Min Daliu(Department of Medical Oncology,Shanghai Sixth People′s Hospital Affiliated to Shanghai Jiao Tong University,Shanghai 201306,China)
出处
《中华诊断学电子杂志》
2019年第3期147-150,共4页
Chinese Journal of Diagnostics(Electronic Edition)
基金
上海市卫生和计划生育委员会卫生行业临床研究专项面上项目(201840039)
上海健康医学院种子基金项目国家级项目培育专项(SFP-18-20-14-002)
2019上海市科委自然科学基金(19ZR1439100)
